Pediatric and adult eosinophilic esophagitis: similarities and differences

Early in the 1990s, several case series described adults suffering from dysphagia and children with refractory reflux symptoms, both accompanied by an eosinophil‐predominant infiltration, thereby conclusively distinguishing it from gastroesophageal reflux disease. Eosinophilic esophagitis (EoE) was recognized as its own entity in the adult and in the pediatric literature. In the last decade, evidence has accumulated that EoE represents a T‐helper (Th)2‐type inflammatory disease. Remodeling of the esophagus is a hallmark of EoE, leading to esophageal dysfunction and bolus impaction. Familial occurrence and disease association with single‐nucleotide polymorphisms underscore the influence of genetics in this disease. Eosinophilic esophagitis may affect individuals at any age, although the clinical presentation is highly age dependent. There is a significant allergic bias in the EoE population, with the majority of patients having concurrent allergic rhinitis, asthma, eczema, and/or a history of atopy. One noteworthy difference is that in children, EoE seems to be primarily a food antigen–driven disease, whereas in adults, mainly aeroallergen sensitization has been observed. Treatment modalities for EoE include the 3Ds: drugs, diet, and dilation. The crucial question of whether adult and pediatric EoE are different phenotypes of one single entity or whether we are confronted with two different diseases is still open. Here, we review similarities and differences between EoE in adults and children.

[1]  M. Zwahlen,et al.  Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. , 2011, The Journal of allergy and clinical immunology.

[2]  H. Ortega,et al.  An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. , 2011, Gastroenterology.

[3]  T. Bellón,et al.  Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. , 2011, The Journal of allergy and clinical immunology.

[4]  H. Simon,et al.  Distinct eosinophil cytokine expression patterns in skin diseases – the possible existence of functionally different eosinophil subpopulations , 2011, Allergy.

[5]  T. Sentongo,et al.  Identification of Specific Foods Responsible for Inflammation in Children With Eosinophilic Esophagitis Successfully Treated With Empiric Elimination Diet , 2011, Journal of pediatric gastroenterology and nutrition.

[6]  A. Schoepfer,et al.  Eosinophilic esophagitis: updated consensus recommendations for children and adults. , 2011, The Journal of allergy and clinical immunology.

[7]  A. Lucendo,et al.  Montelukast Was Inefficient in Maintaining Steroid-Induced Remission in Adult Eosinophilic Esophagitis , 2011, Digestive Diseases and Sciences.

[8]  A. Schoepfer,et al.  Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  H. Simon,et al.  Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. , 2011, The Journal of allergy and clinical immunology.

[10]  A. Straumann,et al.  Relative lack of T regulatory cells in adult eosinophilic esophagitis – no normalization after corticosteroid therapy , 2011, Allergy.

[11]  Kathy M. Spomer,et al.  Eosinophilic esophagitis: recognizing the clues. , 2011, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

[12]  C. Miller,et al.  Tryptase Staining of Mast Cells May Differentiate Eosinophilic Esophagitis from Gastroesophageal Reflux Disease , 2011, The American Journal of Gastroenterology.

[13]  C. Ripoll,et al.  Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  D. Broide,et al.  Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. , 2010, The Journal of allergy and clinical immunology.

[15]  A. Schoepfer,et al.  Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. , 2010, Gastroenterology.

[16]  A. Pandey,et al.  Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice , 2010, Journal of leukocyte biology.

[17]  S. Aceves,et al.  Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. , 2010, Gastroenterology.

[18]  Lisa J. Martin,et al.  Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. , 2010, The Journal of allergy and clinical immunology.

[19]  K. Stringer,et al.  Involvement of mast cells in eosinophilic esophagitis. , 2010, The Journal of allergy and clinical immunology.

[20]  E. King,et al.  Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. , 2010, The Journal of allergy and clinical immunology.

[21]  K. Nadeau,et al.  Increased Number of Regulatory T Cells in Children With Eosinophilic Esophagitis , 2010, Journal of pediatric gastroenterology and nutrition.

[22]  K. Kelleher,et al.  Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  A. Schoepfer,et al.  Esophageal Dilation in Eosinophilic Esophagitis: Effectiveness, Safety, and Impact on the Underlying Inflammation , 2010, The American Journal of Gastroenterology.

[24]  S. Ziegler,et al.  Sensing the outside world: TSLP regulates barrier immunity , 2010, Nature Immunology.

[25]  J. Woosley,et al.  Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. , 2010, Gastrointestinal endoscopy.

[26]  Joseph T. Glessner,et al.  Common variants at 5q22 associate with pediatric eosinophilic esophagitis , 2010, Nature Genetics.

[27]  Lisa J. Martin,et al.  Coordinate Interaction between IL-13 and Epithelial Differentiation Cluster Genes in Eosinophilic Esophagitis , 2010, The Journal of Immunology.

[28]  P. Funch‐jensen,et al.  Acid hypersensitivity in patients with eosinophilic oesophagitis , 2010, Scandinavian journal of gastroenterology.

[29]  R. Wong,et al.  Correlation between eosinophilic oesophagitis and aeroallergens , 2010, Alimentary pharmacology & therapeutics.

[30]  D. Broide,et al.  Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids , 2010, Allergy.

[31]  J. Goldblum,et al.  The Role of Allergy Evaluation in Adults With Eosinophilic Esophagitis , 2010, Journal of clinical gastroenterology.

[32]  C. Prussin,et al.  Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses. , 2009, The Journal of allergy and clinical immunology.

[33]  S. Aceves,et al.  A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[34]  C. Beglinger,et al.  Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial , 2009, Gut.

[35]  A. Zinsmeister,et al.  Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  S. Baker,et al.  Treatment With High-dose Proton Pump Inhibitors Helps Distinguish Eosinophilic Esophagitis From Noneosinophilic Esophagitis , 2009, Journal of pediatric gastroenterology and nutrition.

[37]  M. Vicario,et al.  Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis , 2009, Gut.

[38]  M. Raimondo,et al.  Seasonal Distribution in Newly Diagnosed Cases of Eosinophilic Esophagitis in Adults , 2009, The American Journal of Gastroenterology.

[39]  V. Tam,et al.  A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[40]  R. Wong,et al.  Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  M. Gilger,et al.  Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease. , 2009, Annals of clinical and laboratory science.

[42]  D. Postma,et al.  Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction , 2009, Nature Genetics.

[43]  J. Franciosi,et al.  14 Years of Eosinophilic Esophagitis: Clinical Features and Prognosis , 2009, Journal of pediatric gastroenterology and nutrition.

[44]  M. Stolte,et al.  Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro‐oesophageal reflux disease on oesophageal biopsy material , 2008, Histopathology.

[45]  T. Bellón,et al.  Treatment With Topical Steroids Downregulates IL-5, Eotaxin-1/CCL11, and Eotaxin-3/CCL26 Gene Expression in Eosinophilic Esophagitis , 2008, The American Journal of Gastroenterology.

[46]  A. Straumann,et al.  Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense , 2008, Nature Medicine.

[47]  C. Beglinger,et al.  Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. , 2008, The Journal of allergy and clinical immunology.

[48]  A. Schoepfer,et al.  Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[49]  D. Katzka,et al.  Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. , 2008, Gastroenterology.

[50]  D. Katzka,et al.  Atopic characteristics of adult patients with eosinophilic esophagitis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[51]  I. Hirano,et al.  727 A Prospective Clinical Trial of Six Food Elimination Diet and Reintroduction of Causative Agents in Adults with Eosinophilic Esophagitis (EE) , 2008 .

[52]  J. Croffie,et al.  Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[53]  S. Kethu,et al.  Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. , 2007, Human pathology.

[54]  G. Cleghorn,et al.  Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis , 2007, Allergy.

[55]  A. Straumann,et al.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. , 2007, Gastroenterology.

[56]  R. Weimann,et al.  Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission , 2007, European journal of gastroenterology & hepatology.

[57]  S. Aceves,et al.  Oral Viscous Budesonide: A Potential New Therapy for Eosinophilic Esophagitis in Children , 2007, The American Journal of Gastroenterology.

[58]  H. Sampson,et al.  Esophageal Subepithelial Fibrosis in Children With Eosinophilic Esophagitis , 2007, Journal of pediatric gastroenterology and nutrition.

[59]  M. Collins,et al.  Interplay of Adaptive Th2 Immunity with Eotaxin-3/C-C Chemokine Receptor 3 in Eosinophilic Esophagitis , 2007, Journal of pediatric gastroenterology and nutrition.

[60]  Flint Y Wang,et al.  Is There a Seasonal Variation in the Incidence or Intensity of Allergic Eosinophilic Esophagitis in Newly Diagnosed Children? , 2007, Journal of clinical gastroenterology.

[61]  John C. Fang,et al.  Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis , 2007, Digestive Diseases and Sciences.

[62]  L. Santamaría,et al.  Immunophenotypic Characterization and Quantification of the Epithelial Inflammatory Infiltrate in Eosinophilic Esophagitis Through Stereology: An Analysis of the Cellular Mechanisms of the Disease and the Immunologic Capacity of the Esophagus , 2007, The American journal of surgical pathology.

[63]  S. Aceves,et al.  Distinguishing Eosinophilic Esophagitis in Pediatric Patients: Clinical, Endoscopic, and Histologic Features of An Emerging Disorder , 2007, Journal of clinical gastroenterology.

[64]  R. Noel,et al.  Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. , 2007, The Journal of allergy and clinical immunology.

[65]  E. Cutz,et al.  Activated Mucosal Mast Cells Differentiate Eosinophilic (Allergic) Esophagitis From Gastroesophageal Reflux Disease , 2007, Journal of pediatric gastroenterology and nutrition.

[66]  A. Straumann,et al.  Eosinophilic esophagitis in adults – no clinical relevance of wheat and rye sensitizations , 2006, Allergy.

[67]  M. Rothenberg,et al.  Eosinophilic esophagitis: pathogenesis, genetics, and therapy. , 2006, The Journal of allergy and clinical immunology.

[68]  R. Noel,et al.  A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. , 2006, Gastroenterology.

[69]  T. Sentongo,et al.  Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[70]  M. Ramsay Faculty Opinions recommendation of Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. , 2006 .

[71]  Colin N A Palmer,et al.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.

[72]  M. Stolte,et al.  Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy , 2006, Journal of Clinical Pathology.

[73]  B. Aronow,et al.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.

[74]  P. Mamula,et al.  Eosinophilic esophagitis: a 10-year experience in 381 children. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[75]  S. Bor,et al.  Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[76]  C. Ober Perspectives on the past decade of asthma genetics. , 2005, The Journal of allergy and clinical immunology.

[77]  A. Barkun,et al.  The yield and the predictors of esophageal pathology when upper endoscopy is used for the initial evaluation of dysphagia. , 2005, Gastrointestinal endoscopy.

[78]  A. Straumann,et al.  Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. , 2005, The Journal of allergy and clinical immunology.

[79]  C. Beglinger,et al.  Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. , 2003, Gastroenterology.

[80]  M. Rothenberg,et al.  Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. , 2003, Gastroenterology.

[81]  E. Ruchelli,et al.  Pollen and eosinophilic esophagitis. , 2003, The Journal of allergy and clinical immunology.

[82]  J. Croese,et al.  Clinical and endoscopic features of eosinophilic esophagitis in adults. , 2003, Gastrointestinal endoscopy.

[83]  E. Ruchelli,et al.  Elemental Diet Is an Effective Treatment for Eosinophilic Esophagitis in Children and Adolescents , 2003, American Journal of Gastroenterology.

[84]  K. Badizadegan,et al.  Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. , 2002, Gastroenterology.

[85]  M. Mascarenhas,et al.  The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. , 2002, The Journal of allergy and clinical immunology.

[86]  M. Collins,et al.  Pathogenesis and clinical features of eosinophilic esophagitis. , 2001, The Journal of allergy and clinical immunology.

[87]  U. Wahn,et al.  Childhood risk factors for atopy and the importance of early intervention. , 2001, The Journal of allergy and clinical immunology.

[88]  P. Putnam,et al.  The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children , 2000, American Journal of Gastroenterology.

[89]  N. Talley,et al.  Eosinophil infiltration and degranulation in normal human tissue , 1998, The Anatomical record.

[90]  G. Furuta Eosinophils in the esophagus: acid is not the only cause. , 1998, Journal of pediatric gastroenterology and nutrition.

[91]  H. Sampson,et al.  Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. , 1995, Gastroenterology.

[92]  A. Straumann,et al.  [Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings]. , 1994, Schweizerische medizinische Wochenschrift.

[93]  H. Goldman,et al.  Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. , 1982, Gastroenterology.

[94]  U. Kuhlmann,et al.  [Eosinophilic esophagitis, a rare manifestation of eosinophilic gastroenteritis]. , 1982, Schweizerische medizinische Wochenschrift.

[95]  K. Olden,et al.  Treatment of eosinophilic esophagitis: is oral viscous budesonide superior to swallowed fluticasone spray? , 2011, Gastroenterology & hepatology.

[96]  H. Simon,et al.  Eosinophil extracellular DNA traps in skin diseases. , 2011, The Journal of allergy and clinical immunology.

[97]  Y. Elitsur,et al.  Fluticasone and Food Allergen Elimination Reverse Sub-epithelial Fibrosis in Children with Eosinophilic Esophagitis , 2010, Digestive Diseases and Sciences.

[98]  K. Stringer,et al.  CLINICAL, PATHOLOGICAL AND MOLECULAR CHARACTERIZATION OF FAMILIAL EOSINOPHILIC ESOPHAGITIS COMPARED WITH SPORADIC CASES , 2009 .

[99]  J. Domínguez-Ortega,et al.  Eosinophilic esophagitis due to profilin allergy. , 2009, Journal of investigational allergology & clinical immunology.

[100]  M. Collins,et al.  Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. , 2008, Gastroenterology.

[101]  M. Osterman Oral Viscous Budesonide: A Potential New Therapy for Eosinophilic Esophagitis in Children , 2008 .

[102]  M. Rothenberg,et al.  Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. , 2007, Journal of leukocyte biology.

[103]  D. Jones,et al.  Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. , 2006, Gastrointestinal endoscopy.

[104]  S. Attwood,et al.  Eosinophilic oesophagitis: a novel treatment using Montelukast , 2003, Gut.

[105]  A. Straumann,et al.  Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. , 2001, The Journal of allergy and clinical immunology.

[106]  M. Rothenberg,et al.  An etiological role for aeroallergens and eosinophils in experimental esophagitis. , 2001, The Journal of clinical investigation.

[107]  T. Smyrk,et al.  Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. , 1993, Digestive diseases and sciences.

[108]  G. Kuster,et al.  Eosinophilic esophagitis in a patient with vigorous achalasia. , 1978, Gastroenterology.